Burkitt lymphoma
- C83.7 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM C83.7 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C83.7 – other international versions of ICD-10 C83.7 may differ.
Applicable To
- Atypical Burkitt lymphoma
- Burkitt-like lymphoma
Type 1 Excludes
- mature B-cell leukemia Burkitt type (C91.A-)
The following code(s) above C83.7 contain annotation back-references
that may be applicable to C83.7:
- C00-D49 Neoplasms
- C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C83 Non-follicular lymphoma
Clinical Information
- A form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma. The epstein-barr virus (herpesvirus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative.
- A highly aggressive lymphoma composed of monomorphic medium-sized b-cells with basophilic cytoplasm and numerous mitotic figures. It is often associated with the presence of epstein-barr virus (ebv) and is commonly seen in aids patients. Three morphologic variants are recognized: classical burkitt lymphoma, burkitt lymphoma with plasmacytoid differentiation, and atypical burkitt/burkitt-like lymphoma. All cases express the myc translocation [t(8;14)]. (who, 2001)
- A morphologic variant of burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.
- A rare, fast-growing cancer of the blood. Also called b-cell acute lymphocytic leukemia or b-cell acute lymphoblastic leukemia.
- A rare, fast-growing type of leukemia (blood cancer) in which too many white blood cells called b lymphocytes form in the blood and bone marrow. It may start in the lymph nodes as burkitt lymphoma and then spread to the blood and bone marrow, or it may start in the blood and bone marrow without involvement of the lymph nodes. Both burkitt leukemia and burkitt lymphoma have been linked to infection with the epstein-barr virus.
- A type of non-hodgkin’s lymphoma that most often occurs in young people aged 12-30 years. The disease usually causes a rapidly growing tumor in the abdomen.
- An aggressive (fast-growing) type of b-cell non-hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, bowel, kidneys, ovaries, or other organs. There are three main types of burkitt lymphoma (sporadic, endemic, and immunodeficiency related). Sporadic burkitt lymphoma occurs throughout the world, and endemic burkitt lymphoma occurs in africa. Immunodeficiency-related burkitt lymphoma is most often seen in aids patients.
- Form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world; commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass; b-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma; the epstein-barr virus (human herpesvirus 4) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases, however, most non-african cases are ebv-negative.
- The leukemic counterpart of burkitt’s lymphoma. The characteristic burkitt cells are seen in the bone marrow and the peripheral blood. This is an aggressive leukemia.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to C83.7:
- Type 1 Excludes: C91.A
Diagnosis Index entries containing back-references to C83.7: